Table 1.
Inhibition of tubulin polymerization, percent inhibition of colchicine binding, and cytotoxicity of the target benzosuberene analogues
Compound | Inhibition of tubulin polymerization IC50 (μM) ± SD | % Inhibition of colchicine binding ± SD | GI50 (μM) SRB assaya | ||
---|---|---|---|---|---|
| |||||
SK-OV-3 | NCI-H460 | DU-145 | |||
CA4 | 1.0b | 84 ± 3 (1 μM), 98 ± 0.007 (5 μM) | 0.00455 | 0.00223c | 0.00327c |
CA4P | >40b | nr | 0.00119 | 0.00194c | 0.00323c |
KGP18 | 1.4d | nr | 0.0000543e | 0.0000418e | 0.0000249e |
28 | >20 | nr | 32.7 | 37.5 | 89.3 |
29 | 1.0 ± 0.02 | 37 ± 5 (1 μM), 72 ± 0.8 (5 μM) | 0.0516 | 0.0527 | 0.0619 |
30 | 1.6 ± 0.2 | 65 ± 0.6 (5 μM) | 0.330 | 0.422 | 0.644 |
31 | >20 | nr | 0.568 | 0.763 | 1.51 |
32 | >20 | nr | 2.96 | 3.32 | 6.03 |
33 | >20 | nr | 11.5 | 16.1 | 12.2 |
34 | >20 | nr | 31.1 | 25.5 | 52.1 |
35 | 3.1 ± 0.03 | 30 ± 4 (5 μM), 56 ± 4 (50 μM) | 0.277 | 0.593 | 0.708 |
36 | >20 | nr | 20.5 | 33.4 | 48.3 |
37 | >20 | nr | 40.7 | 57.7 | 68.7 |
61 | >20 | nr | 6.96 | 10.5 | 26.2 |
62 | 1.2 ± 0.007 | 36 ± 5 (1 μM), 69 ± 3 (5 μM) | 0.0432 | 0.120 | 0.0562 |
64 | >20 | nr | 0.557 | 0.652 | 4.40 |
65 | 3.8 ± 0.3 | 8.5 ± 4 (5 μM), 37 ± 5 (50 μM) | 4.81 | 4.39 | 4.92 |
66 | >20 | nr | 16.8 | 25.0 | 21.8 |
67 | 7.4 ± 0.06 | nr | 18.4 | 10.6 | 8.59 |
68 | 2.7 ± 0.1 | 27 ± 5 (5 μM) | 0.527 | 0.647 | 1.02 |
70 | 7.7 ± 0.2 | nr | 0.346 | 0.691 | 1.53 |
71 | 11 ± 0.4 | nr | 3.53 | 4.24 | 7.54 |
72 | 0.70 ± 0.1 | 21 ± 0.9 (1 μM), 67 ± 0.6 (5 μM) | 0.408 | 0.141 | 0.570 |
73 | >20 | nr | 0.357 | 0.145 | 0.753 |
74 | >20 | nr | 17.2 | 16.3 | 17.5 |